New drugs help as AstraZeneca battles through generic losses
LONDON, July 26 (Reuters) - AstraZeneca's new drugs performed strongly in the second quarter, offering a glimpse of better times ahead as the company struggles with falling sales of cholesterol fighter Crestor due to generic competition.
from Google Alert - Business https://ift.tt/2mIXY9a
LONDON, July 26 (Reuters) - AstraZeneca's new drugs performed strongly in the second quarter, offering a glimpse of better times ahead as the company struggles with falling sales of cholesterol fighter Crestor due to generic competition. https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/2mIXY9a
LONDON, July 26 (Reuters) - AstraZeneca's new drugs performed strongly in the second quarter, offering a glimpse of better times ahead as the company struggles with falling sales of cholesterol fighter Crestor due to generic competition. https://ift.tt/eA8V8J
Comments
Post a Comment